The Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) has issued a solicitation for the advanced development and manufacturing of therapeutics for the indication of treating neutropenia arising from acute exposure to ionizing radiation, known as acute radiation syndrome. BARDA is considering a five-year cost reimbursement, multiple contract award effort. Sol. No. BARDA-09-100-SOL-0005. Respond by May 7. Contact: Anthony Kram, contracting specialist, 202-205-4709, [email protected].